North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

October 2022 | 114 pages | ID: N7E8AEB6C997EN
GMD Research

Abstracts

North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.

Highlighted with 32 tables and 43 figures, this 114-page report “North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.

Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Software
• Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

10x Genomics

Agilent Technologies, Inc.

ANGLE plc

Becton, Dickinson and Company (BD)

Bio-Rad Laboratories, Inc.

BioSypder, Inc.

Bio-Techne

Cytiva

F. Hoffmann-La Roche Ltd.

Fluidigm Corporation

GE Healthcare

Illumina, Inc.

Menarini Silicon Biosystems

Merck & Co., Inc.

NanoString

Pacific Biosciences of California, Inc.

PerkinElmer Inc.

Promega Corporation

Qiagen N. V.

Takara Bio Inc.

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY COMPONENT

3.1 Market Overview by Component
3.2 Instruments
3.3 Consumables
3.4 Software
3.5 Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.3 Next-Generation Sequencing
4.4 Microarray
4.5 In-Situ Hybridization (ISH)
4.6 Gene Regulation Technologies
4.7 Other Technologies

5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Drug Discovery and Development
5.3 Diagnostics
5.4 Single Cell Analysis
5.5 Gene Expression
5.6 Cell Biology
5.7 Other Applications

6 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

6.1 Market Overview by End User
6.2 Academic and Research Institutions
6.3 Biotechnology and Biopharmaceutical Companies
6.4 Contract Research Organizations (CROs)
6.5 Other End Users

7 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

7.1 Overview of North America Market
7.2 U.S.
7.3 Canada
7.4 Mexico

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles

10X GENOMICS

Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of North America Transcriptomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Transcriptome Databases
Table 4. World Personalized Medicine Market, 2021-2031, $ bn
Table 5. Main Product Trends and Market Opportunities in North America Transcriptomics Market
Table 6. North America Transcriptomics Market by Component, 2021-2031, $ mn
Table 7. Main Instrument Products from Key Vendors
Table 8. Main Consumable Products from Key Vendors
Table 9. Main Software Products from Key Vendors
Table 10. North America Transcriptomics Market by Technology, 2021-2031, $ mn
Table 11. Main PCR-based Transcriptomics and Key Vendors
Table 12. Main NGS-based Transcriptomics and Key Vendors
Table 13. Main Microarray-based Transcriptomics and Key Vendors
Table 14. Main ISH-based Transcriptomics and Key Vendors
Table 15. North America Transcriptomics Market by Application, 2021-2031, $ mn
Table 16. North America Transcriptomics Market by End User, 2021-2031, $ mn
Table 17. North America Transcriptomics Market by Country, 2021-2031, $ mn
Table 18. U.S. Transcriptomics Market by Component, 2021-2031, $ mn
Table 19. U.S. Transcriptomics Market by Technology, 2021-2031, $ mn
Table 20. U.S. Transcriptomics Market by Application, 2021-2031, $ mn
Table 21. Canada Transcriptomics Market by Component, 2021-2031, $ mn
Table 22. Canada Transcriptomics Market by Technology, 2021-2031, $ mn
Table 23. Canada Transcriptomics Market by Application, 2021-2031, $ mn
Table 24. Mexico Transcriptomics Market by Component, 2021-2031, $ mn
Table 25. Mexico Transcriptomics Market by Technology, 2021-2031, $ mn
Table 26. Mexico Transcriptomics Market by Application, 2021-2031, $ mn
Table 27. Transcriptomic Products Approved by FDA
Table 28. Sequencing Technology Platforms for RNA-Sequencing
Table 29. RNA-Sequencing De Novo Assembly Software
Table 30. 10x Genomics: Company Snapshot
Table 31. 10x Genomics: Business Segmentation
Table 32. 10x Genomics: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America Transcriptomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Transcriptomics Market
Figure 7. Primary Restraints and Impact Factors of North America Transcriptomics Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of North America Transcriptomics Market
Figure 10. Breakdown of North America Transcriptomics Market by Component, 2021-2031, % of Revenue
Figure 11. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)
Figure 12. North America Transcriptomics Market by Component: Instruments, 2021-2031, $ mn
Figure 13. North America Transcriptomics Market by Component: Consumables, 2021-2031, $ mn
Figure 14. North America Transcriptomics Market by Component: Software, 2021-2031, $ mn
Figure 15. North America Transcriptomics Market by Component: Services, 2021-2031, $ mn
Figure 16. Breakdown of North America Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue
Figure 17. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 18. North America Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 19. North America Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn
Figure 20. North America Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn
Figure 21. North America Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn
Figure 22. North America Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn
Figure 23. North America Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 24. Breakdown of North America Transcriptomics Market by Application, 2021-2031, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 26. North America Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn
Figure 27. North America Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn
Figure 28. North America Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn
Figure 29. North America Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn
Figure 30. North America Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn
Figure 31. North America Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn
Figure 32. Breakdown of North America Transcriptomics Market by End User, 2021-2031, % of Revenue
Figure 33. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 34. North America Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn
Figure 35. North America Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn
Figure 36. North America Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 37. North America Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 38. Breakdown of North America Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 39. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 40. U.S. Transcriptomics Market, 2021-2031, $ mn
Figure 41. Canada Transcriptomics Market, 2021-2031, $ mn
Figure 42. Transcriptomics Market in Mexico, 2021-2031, $ mn
Figure 43. Growth Stage of North America Transcriptomics Industry over the Forecast Period